Dr Navneet Majhail
Department:Hematology and Oncology
Location:Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
Appointment: 216.444.2199
Surgeon: No
Type of Doctor: Adults Only
Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of
Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
Dr Navneet Majhail, MD, MS is the Director of the Cleveland Clinic's Blood & Marrow
Transplant Program. He serves as a Staff Physician with the Department of Hematology and
Oncology at the Taussig Cancer Institute and is a Professor of Medicine with the Cleveland
Clinic Lerner College of Medicine. Prior to joining the Cleveland Clinic, Dr Majhail has held
appointments as Adjunct Associate Professor of Medicine with the University of Minnesota
and as Medical Director Health Services Research at the National Marrow Donor Program,
both in Minneapolis. His research focuses on the prevention and management of early and
late complications of blood and marrow transplantation and health policy issues such as
health care disparities, quality of care, survivorship and economic issues related to transplant.
Education & Fellowships
Fellowship - University of Minnesota
Hematology/Oncology
Minneapolis, MN USA
2007
Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
2004
Other - All India Institute of Medical Sciences
Radiation Oncology
New Delhi India
2000
Medical School - Government Medical College
Chandigarh India
1996
Graduate - University of Minnesota
Minneapolis, MN USA
Certifications

Internal Medicine- Hematology
Specialty Interests
Blood and Marrow Transplantation, Leukemia, Lymphoma, Myeloma, Myelofibrosis,
Aplastic Anemia, Other Hematologic Cancers Blood and Marrow Transplantation, Leukemia,
Lymphoma, Myeloma, Other Hematologic Cancers
Treatment & Services

Bone Marrow Transplantation
Specialty In Diseases And Conditions









Aplastic Anemia
Cancer
Hematologic Malignancies
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplasia
Myelodysplastic Syndrome (MDS)
Myeloproliferative Disorders
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or
medical device industries to help develop medical breakthroughs or provide medical
expertise or education. Cleveland Clinic strives to make scientific advances that will benefit
patient care and support outside relationships that promise public benefit. In order for the
discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to
benefit the public, these discoveries must be commercialized in partnership with industry. As
experts in their fields, Cleveland Clinic physicians and scientists are often sought after by
industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains
a program that reviews these collaborations and, when appropriate, puts measures in place to
minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the
names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in
rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists
serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties
or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as
inventor, discoverer, developer, founder or consultant.* In publicly disclosing this
information, Cleveland Clinic tries to provide information as accurately as possible about its
physicians' and scientists' connections with industry.
As of 1/26/2015, Dr. Majhail has reported no financial relationship with industry that is
applicable to this listing. In general, patients should feel free to contact their doctor about any
of the relationships and how the relationships are overseen by Cleveland Clinic. To learn
more about Cleveland Clinic's policies on collaborations with industry and innovation
management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic
scientists and physicians engage in basic, translational and clinical research activities,
working to solve health problems, enhance patient care and improve quality of life for
patients. Interactions with industry are essential to bringing the researchers’ discoveries to the
public, but can present the potential for conflicts of interest related to their research
activities. Click here to view a listing of instances where Cleveland Clinic has identified a
Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures
in place to ensure that, to the extent possible, the design, conduct and reporting of the
research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the
PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of
Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are
generally prohibited.